CLGN - CollPlant Biotechnologies Ltd Ordinary Shares

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.4 -0.07 (-2.92%)	---	---	0.0 (0.0%)	0.14 (5.83%)	-0.18 (-7.17%)	---	0.14 (5.83%)

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Category: /stock/categories/na

Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 2.33
RVol:: 0.256

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.43 -0.02 (-1.02%)	Oct 16 12:11
1m	Price increase 1m	2.6 +0.1 (+3.91%)	Oct 16 10:44
10m	Price increase 10m	2.6 +0.1 (+3.9%)	Oct 16 10:44
60m	Price increase 60m	2.6 +0.13 (+5.17%)	Oct 16 10:44
1m	Price decrease 1m	2.46 -0.03 (-1.2%)	Oct 16 10:09